![Lisa Sinclair](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Lisa Sinclair is Senior Vice President-Corporate Operations at Arvinas, Inc. since 2022.
Formerly, Ms. Sinclair was VP-Global R&D Portfolio & Performance at AstraZeneca, Inc., Head-Programs & Alliance Management at Springworks Therapeutics, Inc., and Head-Corporate & Commercial Strategy at Rallybio Corp.
Education includes undergraduate studies at the University of Vermont.
Aktiva positioner av Lisa Sinclair
| Företag | Position | Start |
|---|---|---|
| ARVINAS, INC. | Verksamhetschef | 2022-08-15 |
Tidigare kända positioner av Lisa Sinclair
| Företag | Position | Slut |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Företagsledare/Principal | - |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Företagsledare/Principal | - |
| RALLYBIO CORPORATION | Företagsledare/Principal | - |
Lisa Sinclairs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
30
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Springworks Therapeutics, Inc.
 Springworks Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for treating cancer | Health Technology |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
